Deals Intelligence
The Deals Intelligence API provides comprehensive biopharma deals information, helping you search for potential partners, conduct due diligence, assess deal value and explore deal structures and terms. From broad market wide trends to tightly focused comparables, the Deals Intelligence API helps you negotiate the best deal.
Deals Intelligence API can help you to
- Develop and implement strategic partnering plans
- Understand timing for partnering
- Supplement resources for specific licensing opportunities or business development strategies
- Build accurate comparables for deals and alliances
- Create a “short-list” of prospective partners
- Review deal histories of prospective partners
Content
- Key information on a deal including the parties involved, deal type, territories, total projected value, indications and technologies
- Drug involved in the deal and the highest phase for the drug currently and at the time the deal started
- Patent information or contracts available for the deal
- Summary of the deal in addition to a detailed breakout of individual events with dates, event types and related drugs and payments
- Detailed financials including milestones, equity, upfront payments and royalty rates. This can include tables for projected at-signing, projected current, and paid
- If the deal is a merger or acquisition, information will be available
Entities diagram (Colour coding – green: main entity | purple: supporting entities)
Search / export deal results; Retrieve / export deal records and contracts when available; Export either all available data for the selected deal records in a plain Excel format or a summary tables with focus on deal finance data (sample charts and pivot table).